Global Pharmacovigilance Market Research Report

1. Global Pharmacovigilance Market Research Report According to a new market research report published by Global Market Estimates, the Global Pharmacovigilance Market is expected to grow at a CAGR of 13.55% during the forecast period. The demand for pharmacovigilance is projected to be high due to the increasing demand for pharmacovigilance services and rising cost-effective initiatives for SMEs companies. Browse 145 Market Data Tables and 118 Figures spread through 168 Pages and in-depth TOC on "Pharmacovigilance Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-pharmacovigilance-market-2361 By Product Life Cycle (Pre-Clinical, Phase I, Phase II, Phase III, Phase IV), By Type of Service Provider (In-house, Contract Outsourcing), By Type (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining), By Therapeutic Area (Oncology, Neurology, Cardiology, Respiratory Systems, Others), By End-Use (Pharmaceuticals, Biotechnology Companies, Medical Device Manufacturers, Others), By Process Flow (Case Data Management, Signal Detection, Risk Management System), By Region (North America, Europe, Asia Pacific and Rest of the World); and Company Market Share Analysis & Competitor Analysis Key Market Insights Pharmacovigilance is the study of science and practices involved in the diagnosis, awareness, review and prevention of adverse drug effects or other drug-related concerns The rising number of endemic diseases such as diabetes and respiratory disorders, among others The Phase IV segment will be the fastest-growing segment to hold the biggest market share in terms of revenue in the global market in terms of product life cycle from 2020 to 2026  The in-house segment projected to grow faster at a highest CAGR than the contract- outsourcing in the global pharmacovigilance market in 2020-2026 The Asia-Pacific will grow the fastest during the forecast period and North America as the largest segment in terms of revenue over the coming years Major players in the pharmacovigilance market include Wipro Ltd., Laboratory Corporation of America Holdings, ArisGlobal, ICON plc., Capgemini, IBM Corporation, ITClinical, FMD K&L, Accenture, IQVIA, TAKE Solutions Ltd., Linical Accelovance, Cognizant, PAREXEL International Corporation, BioClinica Inc., and United BioSource Corporation, among others.

2. Browse pharmacovigilance-market-2361 the Report @ https://www.globalmarketestimates.com/market-report/global- Product Life Cycle Outlook (Revenue, USD Million, 2020-2026) Pre-Clinical Phase I Phase II Phase III Phase IV Type of Service Provider Outlook (Revenue, USD Million, 2020-2026) In-house Contract Outsourcing Type Outlook (Revenue, USD Million, 2020-2026) Spontaneous Reporting Intensified ADR Reporting Targeted Spontaneous Reporting Cohort Event Monitoring EHR Mining Therapeutic Area Outlook (Revenue, USD Million, 2020-2026) Oncology Neurology Cardiology Respiratory Systems Others End-Use Outlook (Revenue, USD Million, 2020-2026) Pharmaceuticals Biotechnology Companies Medical Device Manufacturers

3. Others Process Flow Outlook (Revenue, USD Million, 2020-2026) Case Data Management Signal Detection Risk Management System Regional Outlook (Revenue, USD Million, 2020-2026) North America U.S. Canada Mexico Europe Germany UK France Spain Italy Rest of Europe Asia Pacific China India Japan South Korea Australia Rest of APAC Central & South America Brazil Argentina Rest of CSA

4. Middle East & Africa Saudi Arabia UAE Rest of MEA Contact: Tracy Simon Email address: tracy.simon@globalmarketestimates.com Phone Number: +16026667238 Website: https://www.globalmarketestimates.com/ Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php